Cognitive and Behavioral Effects of Antiepileptic Drugs

Kimford J. Meador, Frank G. Gilliam, Andres M Kanner, John M. Pellock

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The burden of epilepsy extends beyond the physical seizure activity to encumber multiple aspects of an individual's life: independence, employment, education, social confidence, self-esteem, relationships, finances, medical management, stability, future planning, pregnancy, cognitive function, and mental health form only a partial list. Seizure freedom through successful treatment can reclaim much in the individual's life that had previously been controlled by either the occurrence or risk of seizures. Seizure freedom, however, is not achievable in all patients, nor is it without risk of cognitive or behavioral impairment or neurotoxicity due to adverse effects of AEDs. To optimize seizure control, an AED must be selected from among those most efficacious for the patient's epilepsy type. To maximize cognitive and behavioral function, the AED with the best cognitive and behavioral profile and the lowest neurotoxicity is typically the best choice. AEDs traditionally selected for first-line treatment, while efficacious for many patients, have rather unfavorable cognitive, behavioral, and neurotoxicity profiles. Clinical trials of newer AEDs demonstrate that these agents provide the same efficacy with minimal cognitive and behavioral impairment and neurotoxicity. For individuals who do not achieve a seizure-free status, HRQOL studies show that improved cognitive and behavioral function and reduced neurotoxicity contribute to an improved QOL.

Original languageEnglish (US)
JournalEpilepsy and Behavior
Volume2
Issue number4
DOIs
StatePublished - Aug 2001
Externally publishedYes

Fingerprint

Anticonvulsants
Seizures
Cognition
Epilepsy
Self Concept
Mental Health
Clinical Trials
Exercise
Education
Pregnancy
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Cognitive and Behavioral Effects of Antiepileptic Drugs. / Meador, Kimford J.; Gilliam, Frank G.; Kanner, Andres M; Pellock, John M.

In: Epilepsy and Behavior, Vol. 2, No. 4, 08.2001.

Research output: Contribution to journalArticle

Meador, Kimford J. ; Gilliam, Frank G. ; Kanner, Andres M ; Pellock, John M. / Cognitive and Behavioral Effects of Antiepileptic Drugs. In: Epilepsy and Behavior. 2001 ; Vol. 2, No. 4.
@article{bfbb1d3cd850422fa6d8a4d0e8d29802,
title = "Cognitive and Behavioral Effects of Antiepileptic Drugs",
abstract = "The burden of epilepsy extends beyond the physical seizure activity to encumber multiple aspects of an individual's life: independence, employment, education, social confidence, self-esteem, relationships, finances, medical management, stability, future planning, pregnancy, cognitive function, and mental health form only a partial list. Seizure freedom through successful treatment can reclaim much in the individual's life that had previously been controlled by either the occurrence or risk of seizures. Seizure freedom, however, is not achievable in all patients, nor is it without risk of cognitive or behavioral impairment or neurotoxicity due to adverse effects of AEDs. To optimize seizure control, an AED must be selected from among those most efficacious for the patient's epilepsy type. To maximize cognitive and behavioral function, the AED with the best cognitive and behavioral profile and the lowest neurotoxicity is typically the best choice. AEDs traditionally selected for first-line treatment, while efficacious for many patients, have rather unfavorable cognitive, behavioral, and neurotoxicity profiles. Clinical trials of newer AEDs demonstrate that these agents provide the same efficacy with minimal cognitive and behavioral impairment and neurotoxicity. For individuals who do not achieve a seizure-free status, HRQOL studies show that improved cognitive and behavioral function and reduced neurotoxicity contribute to an improved QOL.",
author = "Meador, {Kimford J.} and Gilliam, {Frank G.} and Kanner, {Andres M} and Pellock, {John M.}",
year = "2001",
month = "8",
doi = "10.1006/ebeh.2001.0235",
language = "English (US)",
volume = "2",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Cognitive and Behavioral Effects of Antiepileptic Drugs

AU - Meador, Kimford J.

AU - Gilliam, Frank G.

AU - Kanner, Andres M

AU - Pellock, John M.

PY - 2001/8

Y1 - 2001/8

N2 - The burden of epilepsy extends beyond the physical seizure activity to encumber multiple aspects of an individual's life: independence, employment, education, social confidence, self-esteem, relationships, finances, medical management, stability, future planning, pregnancy, cognitive function, and mental health form only a partial list. Seizure freedom through successful treatment can reclaim much in the individual's life that had previously been controlled by either the occurrence or risk of seizures. Seizure freedom, however, is not achievable in all patients, nor is it without risk of cognitive or behavioral impairment or neurotoxicity due to adverse effects of AEDs. To optimize seizure control, an AED must be selected from among those most efficacious for the patient's epilepsy type. To maximize cognitive and behavioral function, the AED with the best cognitive and behavioral profile and the lowest neurotoxicity is typically the best choice. AEDs traditionally selected for first-line treatment, while efficacious for many patients, have rather unfavorable cognitive, behavioral, and neurotoxicity profiles. Clinical trials of newer AEDs demonstrate that these agents provide the same efficacy with minimal cognitive and behavioral impairment and neurotoxicity. For individuals who do not achieve a seizure-free status, HRQOL studies show that improved cognitive and behavioral function and reduced neurotoxicity contribute to an improved QOL.

AB - The burden of epilepsy extends beyond the physical seizure activity to encumber multiple aspects of an individual's life: independence, employment, education, social confidence, self-esteem, relationships, finances, medical management, stability, future planning, pregnancy, cognitive function, and mental health form only a partial list. Seizure freedom through successful treatment can reclaim much in the individual's life that had previously been controlled by either the occurrence or risk of seizures. Seizure freedom, however, is not achievable in all patients, nor is it without risk of cognitive or behavioral impairment or neurotoxicity due to adverse effects of AEDs. To optimize seizure control, an AED must be selected from among those most efficacious for the patient's epilepsy type. To maximize cognitive and behavioral function, the AED with the best cognitive and behavioral profile and the lowest neurotoxicity is typically the best choice. AEDs traditionally selected for first-line treatment, while efficacious for many patients, have rather unfavorable cognitive, behavioral, and neurotoxicity profiles. Clinical trials of newer AEDs demonstrate that these agents provide the same efficacy with minimal cognitive and behavioral impairment and neurotoxicity. For individuals who do not achieve a seizure-free status, HRQOL studies show that improved cognitive and behavioral function and reduced neurotoxicity contribute to an improved QOL.

UR - http://www.scopus.com/inward/record.url?scp=18044404859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044404859&partnerID=8YFLogxK

U2 - 10.1006/ebeh.2001.0235

DO - 10.1006/ebeh.2001.0235

M3 - Article

VL - 2

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 4

ER -